5-HT1B/1D serotonin receptor agonist attenuates nitroglycerin-evoked nitric oxide synthase expression in trigeminal pathway

Cephalalgia

Volumn 23, Issue 8, 2003, Pages 825-832

  Suwattanasophon, C ^a   Phansuwan Pujito, P ^b   Srikiatkhachorn, Anan ^a  

^a CHULALONGKORN UNIVERSITY   (Thailand)

^b THAMMASAT UNIVERSITY   (Thailand)

Author keywords

5 HT1B 1D receptor; Migraine; Nitric oxide; Nitric oxide synthase; Trigeminal system

Indexed keywords

GLYCERYL TRINITRATE; NITRIC OXIDE SYNTHASE; SEROTONIN 1B AGONIST; SEROTONIN 1B RECEPTOR; SEROTONIN 1D AGONIST; SEROTONIN 1D RECEPTOR; SUMATRIPTAN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD FLOW; BRAIN BLOOD FLOW; BRAIN CORTEX; BRAIN REGION; CAUDATE NUCLEUS; CEREBRAL HYPEREMIA; CONTROLLED STUDY; DRUG MECHANISM; EVOKED RESPONSE; HYPEREMIA; MALE; NERVE CELL; NERVE FIBER; NONHUMAN; PROTEIN EXPRESSION; PROTEIN FUNCTION; RAT; SUPERIOR SAGITTAL SINUS; TRIGEMINAL NUCLEUS; TRIGEMINUS GANGLION;

ANIMALS; GENE EXPRESSION REGULATION; MALE; NITRIC OXIDE SYNTHASE; NITRIC OXIDE SYNTHASE TYPE I; NITROGLYCERIN; RATS; RATS, WISTAR; RECEPTOR, SEROTONIN, 5-HT1B; RECEPTOR, SEROTONIN, 5-HT1D; SEROTONIN AGONISTS; TRIGEMINAL NERVE;

EID: 0141924638     PISSN: 03331024     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1468-2982.2003.00583.x     Document Type: Article

References (18)

1. Anthony M, Hinterberger H, Lance JW. The possible relationship of serotonin to the migraine syndrome. Res Clin Stud Headache 1969; 2:59-69.
2. Sarchielli P, Alberti A, Codini M, Floridi A, Gallai V. Nitric oxide metabolites, prostaglandins and trigeminal vasoactive peptides in internal jugular vein blood during spontaneous migraine attacks. Cephalalgia 2000; 20:907-18.
3. Srikiatkhachorn A, Anuntasethakul T, Maneesri S, Phansuwan-Pujito P, Patumraj S, Kasantikul V. Hyposerotonin-induced nitric oxide supersensitivity in the cerebral microcirculation. Headache 2000; 40:267-75.
4. 2A receptor activation and nitric oxide synthesis: a possible mechanism determining migraine attacks. Headache 2002; 42:566-74.
5. 1B-immunoreactivity within the human trigemino-cerebrovascular system: implications for the discovery of new antimigraine drugs. Cephalalgia 1997; 17:833-42.
6. Goadsby PJ, Edvinsson L. The trigeminovascular system and migraine: studies characterizing cerebrovascular and neuropeptide changes seen in humans and cats. Ann Neurol 1993; 33:48-56.
7. 3H]sumatriptan-binding sites in post-mortem human brain. Cephalalgia 1996; 16:317-22.
8. Zimmerman M. Ethical guidelines for investigations of experimental pain in conscious animals. Pain 1983; 16:109-10.
9. Nozaki K, Moskowitz MA, Boccalini P. CP-93,129, sumatriptan, dihydroergotamine block c-fos expression within rat trigeminal nucleus caudalis caused by chemical stimulation of the meninges. Br J Pharmacol 1992; 106:409-15.
10. Christiansen I, Thomsen LL, Daugaard D, Ulrich V, Olesen J. Glyceryl trinitrate induces attacks of migraine without aura in sufferers of migraine with aura. Cephalalgia 1999; 19:660-7.
11. Tassorelli C, Joseph SA. NADPH-diaphorase activity and Fos expression in brain nuclei following nitroglycerin administration. Brain Res 1995; 695:37-44.
12. Pardutz A, Krizbai I, Multon S, Vecsei L, Schoenen J. Systemic nitroglycerin increases nNOS levels in rat trigeminal nucleus caudalis. Neuroreport 2000; 11:3071-5.
13. Reuter U, Bolay H, Jansen-Olesen I, Chiarugi A, Sanchez del Rio M, Letourneau R et al. Delayed inflammation in rat meninges: implications for migraine pathophysiology. Brain 2001; 124:2490-502.
14. Read SJ, Manning P, McNeil CJ, Hunter AJ, Parsons AA. Effects of sumatriptan on nitric oxide and Superoxide balance during glyceryl trinitrate infusion in the rat. Implications for antimigraine mechanisms. Brain Res 1999; 847:1-8.
15. Read SJ, Hirst WD, Upton N, Parsons AA. Cortical spreading depression produces increased cGMP levels in cortex and brain stem that is inhibited by tonabersat (SB-220453) but not sumatriptan. Brain Res 2001; 891:69-77.
16. Akerman S, Williamson D, Kaube H, Goadsby P. The effect of anti-migraine compounds on nitric oxide-induced dilation of durai meningeal vessels. Eur J Pharmacol 2002; 452:223.
17. Stepien A, Chalimoniuk M, Strosznajder J. Serotonin 5HT1B/1D receptor agonists abolish NMDA receptor-evoked enhancement of nitric oxide synthase activity and cGMP concentration in brain cortex slices. Cephalalgia 1999; 19:859-65.
18. Ayajiki K, Fujioka H, Noda K, Okamura T, Toda N. Modification by sumatriptan and acetylcholine of nitric oxide-mediated neurogenic dilatation in dog cerebral arteries. Eur J Pharmacol 2001; 420:67-72.